Valuation : Ipca Laboratories Limited

Market Cap 498B 5.24B 4.51B 4.24B 3.87B 7.23B 7.26B 50.27B 19.43B 254B 19.66B 19.23B 804B P/E 2027 *
32.8x
P/E 2028 * 28.1x
Enterprise Value 488B 5.12B 4.41B 4.15B 3.78B 7.08B 7.11B 49.2B 19.02B 248B 19.24B 18.82B 787B EV / Sales 2027 *
4.43x
EV / Sales 2028 * 3.9x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.31%
1 day-0.21%
1 week-1.12%
Current month-0.58%
1 month+13.06%
3 months+19.17%
6 months+31.74%
Current year+37.90%
1 week 1,907.6
Extreme 1907.6
1,988.75
1 month 1,671.65
Extreme 1671.65
1,999
Current year 1,392
Extreme 1392
1,999
1 year 1,252.95
Extreme 1252.95
1,999
3 years 870.05
Extreme 870.05
1,999
5 years 670
Extreme 670
1,999
10 years 200
Extreme 200
1,999
Manager TitleAgeSince
Chief Executive Officer 53 2023-03-31
Chief Executive Officer 70 2023-03-31
Chief Tech/Sci/R&D Officer 52 2023-10-15
Director TitleAgeSince
Chairman 79 2012-07-04
Director/Board Member 53 2008-11-10
Director/Board Member 70 1994-07-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-1.12% - - 5.26B
-0.30%-3.29%+49.47%+88.38% 1,002B
-0.19%-2.44%+51.73%+65.07% 649B
+0.49%-4.57%+18.69%+67.57% 440B
-0.80%-0.43%+28.92%+36.94% 346B
-0.13%-14.97%+9.41%+26.44% 263B
-1.90%-2.72%-2.72%+10.93% 250B
-0.15%-11.76%+39.57%+49.30% 213B
-1.06%-4.23%-14.70%-57.76% 201B
-0.54%-2.67%+25.79%+89.01% 182B
Average -0.45%-2.06%+22.90%+41.76% 393.74B
Weighted average by Cap. -0.35%-2.39%+31.96%+55.86%

Financials

2027 *2028 *
Net sales 110B 1.16B 994M 936M 853M 1.6B 1.6B 11.1B 4.29B 56.02B 4.34B 4.24B 177B 123B 1.29B 1.11B 1.04B 952M 1.78B 1.79B 12.38B 4.78B 62.49B 4.84B 4.74B 198B
Net income 15.15B 159M 137M 129M 118M 220M 221M 1.53B 591M 7.72B 598M 585M 24.44B 17.8B 187M 161M 152M 138M 258M 259M 1.8B 694M 9.07B 702M 687M 28.72B
Net Debt -10.65B -112M -96.31M -90.68M -82.63M -155M -155M -1.07B -415M -5.43B -420M -411M -17.19B -19.96B -210M -180M -170M -155M -290M -291M -2.01B -778M -10.17B -788M -770M -32.21B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26-09-09 1,963.70 -0.21% 5,626
26-09-08 ₹1,967.80 +0.44% 12,948
26-09-07 ₹1,959.15 -0.30% 5,414
26-09-04 ₹1,965.10 +0.51% 5,264
26-09-03 ₹1,955.20 -0.06% 46,969
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,963.60INR
Average target price
1,972.28INR
Spread / Average Target
+0.44%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!